SCHEMBL5404004

SCHEMBL5404004

CC(=O)Nc1ccc(-c2c3c(=O)n(C)c(=O)n(CC(C)C)c3nn2Cc2c[nH]nc2-c2ccccc2)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.40
TP53 P04637 1/20 0.40
PDE1A P54750 2/20 0.39
PDE1B Q01064 2/20 0.39
PDE1C Q14123 2/20 0.39
DPP4 P27487 1/20 0.39
PKM P14618 1/20 0.37
LMNA P02545 2/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
ALDH1A1 P00352 1/20 0.35
HPGD P15428 1/20 0.35
HSD17B10 Q99714 1/20 0.35
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
GPR18 Q14330 1/20 0.34
STAT3 P40763 1/20 0.34
HTT P42858 1/20 0.34
TSHR P16473 1/20 0.34
ADORA2B P29275 1/20 0.34
ADORA1 P30542 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5393473 0.85 KMT2A (0.40) MAPTPDE1APDE1BPDE1CDPP4
SCHEMBL5405288 0.83 SLC16A1 (0.47) MAPTTP53PDE1APDE1BPDE1C
SCHEMBL5405558 0.82 SLC16A1 (0.47) MAPTTP53PDE1APDE1BPDE1C
SCHEMBL5407589 0.82 PDE1A (0.38) MAPTPDE1APDE1BPDE1CLMNA
SCHEMBL6659477 0.81 TP53 (0.41) MAPTTP53PDE1APDE1BPDE1C
SCHEMBL5400652 0.81 MAPT (0.48) MAPTTP53PDE1APDE1BPDE1C
SCHEMBL5407653 0.81 TP53 (0.40) MAPTTP53PDE1APDE1BPDE1C
SCHEMBL5400727 0.81 TP53 (0.39) MAPTTP53PDE1APDE1BPDE1C
SCHEMBL5415120 0.81 PDE1A (0.37) MAPTPDE1APDE1BPDE1CLMNA
SCHEMBL5405716 0.81 TP53 (0.44) MAPTTP53PDE1APDE1BPDE1C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7285558-B2 Pyrazolo[3,4-d]pyrimidines inhibiting H. pylori infections ASTRAZENECA AB (SE) 2007-10-23 US disclosed
US-20040254183-A1 Pyrazolo[3,4-d]pyrimidines inhibiting h. pylori infections ASTRAZENECA AB (SE) 2004-12-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040254183-A1 Pyrazolo[3,4-d]pyrimidines inhibiting h. pylori infections DPYD, HPGDS, PGC MAPT 4180/4885TP53 1580/4885PDE1A 4056/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.